Organoid thực quản: ứng dụng và triển vọng tương lai

Uhlenhopp DJ, Then EO, Sunkara T et al (2020) Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 13(6):1010–1021. https://doi.org/10.1007/s12328-020-01237-x Peters Y, Al-Kaabi A, Shaheen NJ et al (2019) Barrett oesophagus Nat Rev Dis Primers 5(1):35. https://doi.org/10.1038/s41572-019-0086-z GBD (2017) Oesophageal Cancer Collaborators (2020) The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(6):582–597. https://doi.org/10.1016/S2468-1253(20)30007-8 Sawas T, Killcoyne S, Iyer PG et al (2018) Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts. Gastroenterology 155(6):1720–1728.e4. https://doi.org/10.1053/j.gastro.2018.08.036 Molina-Infante J, Schoepfer AM, Lucendo AJ et al (2017) Eosinophilic esophagitis: what can we learn from Crohn’s disease? United European Gastroenterol J 5(6):762–772. https://doi.org/10.1177/2050640616672953 Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0 Ishimura N, Okimoto E, Shibagaki K et al (2021) Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig Endosc 33(5):708–719 Rossi G, Manfrin A, Lutolf MP (2018) Progress and potential in organoid research. Nat Rev Genet 19(11):671–687. https://doi.org/10.1038/s41576-018-0051-9 Sato T, Vries RG, Snippert HJ et al (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459(7244):262–265. https://doi.org/10.1038/nature07935 Nguyen R, Da Won BS, Qiao L et al (2021) Developing liver organoids from induced pluripotent stem cells (iPSCs): an alternative source of organoid generation for liver cancer research. Cancer Lett 508:13–17. https://doi.org/10.1016/j.canlet.2021.03.017 Zhu X, Zhang B, He Y et al (2021) Liver organoids: formation strategies and biomedical applications. Tissue Eng Regen Med 18(4):573–585. https://doi.org/10.1007/s13770-021-00357-w Hohwieler M, Illing A, Hermann PC et al (2017) Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling. Gut 66(3):473–486. https://doi.org/10.1136/gutjnl-2016-312423 Grenier K, Kao J, Diamandis P (2020) Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Mol Psychiatry 25(2):254–274. https://doi.org/10.1038/s41380-019-0500-7 Seidlitz T, Merker SR, Rothe A et al (2019) Human gastric cancer modelling using organoids. Gut 68(2):207–217. https://doi.org/10.1136/gutjnl-2017-314549 Quante M, Bhagat G, Abrams JA et al (2012) Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21(1):36–51. https://doi.org/10.1016/j.ccr.2011.12.004 Tang XH, Knudsen B, Bemis D et al (2004) Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 10(1 Pt 1):301–313. https://doi.org/10.1158/1078-0432.ccr-0999-3 Stairs DB, Bayne LJ, Rhoades B et al (2011) Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 19(4):470–483. https://doi.org/10.1016/j.ccr.2011.02.007 Opitz OG, Harada H, Suliman Y et al (2002) A mouse model of human oral-esophageal cancer. J Clin Invest 110(6):761–769. https://doi.org/10.1172/JCI15324 Camilleri AE, Nag S, Russo AR et al (2021) Gene therapy for a murine model of eosinophilic esophagitis. Allergy 76(9):2740–2752. https://doi.org/10.1111/all.14822 Kawaura Y, Tatsuzawa Y, Wakabayashi T et al (2001) Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett’s esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model. J Gastroenterol 36(9):595–600. https://doi.org/10.1007/s005350170042 Kadirkamanathan SS, Yazaki E, Evans DF et al (2001) An ambulant porcine model of acid reflux used to evaluate endoscopic gastroplasty. Gut 44(6):782–788. https://doi.org/10.1136/gut.44.6.782 Kapoor H, Lohani KR, Lee TH et al (2015) Animal models of Barrett’s esophagus and esophageal adenocarcinoma-past, present, and future. Clin Transl Sci 8(6):841–847. https://doi.org/10.1111/cts.12304 Kruger L, Gonzalez LM, Pridgen TA et al (2017) Ductular and proliferative response of esophageal submucosal glands in a porcine model of esophageal injury and repair. Am J Physiol Gastrointest Liver Physiol 313(3):G180–G191. https://doi.org/10.1152/ajpgi.00036.2017 Harada H, Nakagawa H, Oyama K et al (2003) Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 1(10):729–738 Harada H, Nakagawa H, Takaoka M et al (2008) Cleavage of MCM2 licensing protein fosters senescence in human keratinocytes. Cell Cycle 7(22):3534–3538. https://doi.org/10.4161/cc.7.22.7043 Ohashi S, Natsuizaka M, Wong GS et al (2010) Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res 70(10):4174–4184. https://doi.org/10.1158/0008-5472.CAN-09-4614 Ohashi S, Natsuizaka M, Yashiro-Ohtani Y et al (2010) NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 139(6):2113–2123. https://doi.org/10.1053/j.gastro.2010.08.040 Whelan KA, Muir AB, Nakagawa H (2018) Esophageal 3D culture systems as modeling tools in esophageal epithelial pathobiology and personalized medicine. Cell Mol Gastroenterol Hepatol 5(4):461–478. https://doi.org/10.1016/j.jcmgh.2018.01.011 Yoshida GJ (2020) Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol 13(1):4. https://doi.org/10.1186/s13045-019-0829-z Lan T, Xue X, Dunmall LC et al (2021) Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers. Aging 13(8):1227–12293. https://doi.org/10.18632/aging.202934 Dodbiba L, Teichman J, Fleet A et al (2013) Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment. Lab Invest 93(4):397–407. https://doi.org/10.1038/labinvest.2013.8 Dodbiba L, Teichman J, Fleet A et al (2015) Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers. PLoS One 10(3):e0121872. https://doi.org/10.1371/journal.pone.0121872 Sanchez-Vega F, Hechtman JF, Castel P et al (2019) EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer. Cancer Discov 9(2):199–209. https://doi.org/10.1158/2159-8290.CD-18-0598 Ebbing EA, van der Zalm AP, Steins A et al (2019) Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci U S A 116(6):2237–2242. https://doi.org/10.1073/pnas.1820459116 Clevers H (2016) Modeling development and disease with organoids. Cell 165:1586–1597 Sachdeva UM, Shimonosono M, Flashner S et al (2021) Understanding the cellular origin and progression of esophageal cancer using esophageal organoids. Cancer Lett 509:39–52. https://doi.org/10.1016/j.canlet.2021.03.031 Zhang Y, Yang Y, Jiang M et al (2018) 3D Modeling of esophageal development using human PSC-derived basal progenitors reveals a critical role for Notch signaling. Cell Stem Cell 23(4):516–529.e5. https://doi.org/10.1016/j.stem.2018.08.009 Trisno SL, Philo KED, McCracken KW et al (2018) Esophageal organoids from human pluripotent stem cells delineate Sox2 functions during esophageal specification. Cell Stem Cell 23(4):501–515.e7. https://doi.org/10.1016/j.stem.2018.08.008 Schutgens F, Clevers H (2020) Human organoids: tools for understanding biology and treating diseases. Annu Rev Pathol 15:211–234. https://doi.org/10.1146/annurev-pathmechdis-012419-032611 Brassard JA, Lutolf MP (2019) Engineering stem cell self-organization to build better organoids. Cell Stem Cell 24:860–876. https://doi.org/10.1016/j.stem.2019.05.005 Tang XY, Wu S, Wang D et al (2022) Human organoids in basic research and clinical applications. Signal Transduct Target Ther 7(1):168. https://doi.org/10.1038/s41392-022-01024-9 Jiminez JA, Uwiera TC, Douglas Inglis G et al (2015) Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathog 7:29. https://doi.org/10.1186/s13099-015-0076-y Sasai Y (2013) Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell 12(5):520–530. https://doi.org/10.1016/j.stem.2013.04.009 He S, Hu B, Li C et al (2018) PDXliver: a database of liver cancer patient derived xenograft mouse models. BMC Cancer 18(1):550. https://doi.org/10.1186/s12885-018-4459-6 DeWard AD, Cramer J, Lagasse E (2014) Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population. Cell Rep 9(2):701–711. https://doi.org/10.1016/j.celrep.2014.09.027 Kasagi Y, Chandramouleeswaran PM, Whelan KA et al (2018) The esophageal organoid system reveals functional interplay between notch and cytokines in reactive epithelial changes. Cell Mol Gastroenterol Hepatol 5(3):333–352. https://doi.org/10.1016/j.jcmgh.2017.12.013 Bailey DD, Zhang Y, van Soldt BJ et al (2019) Use of hPSC-derived 3D organoids and mouse genetics to define the roles of YAP in the development of the esophagus. Development 146(23):dev178855. https://doi.org/10.1242/dev.178855 Sato T, Stange DE, Ferrante M et al (2011) Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141(5):1762–1772. https://doi.org/10.1053/j.gastro.2011.07.050 Li X, Francies HE, Secrier M et al (2018) Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics. Nat Commun 9(1):2983. https://doi.org/10.1038/s41467-018-05190-9 Kijima T, Nakagawa H, Shimonosono M et al (2018) Three-dimensional organoids reveal therapy resistance of esophageal and oropharyngeal squamous cell carcinoma cells. Cell Mol Gastroenterol Hepatol 7(1):73–91. https://doi.org/10.1016/j.jcmgh.2018.09.003 Karakasheva T A, Kijima T, Shimonosono M et al (2020) Generation and characterization of patient-derived head and neck, oral, and esophageal cancer organoids. Curr Protoc Stem Cell Biol 53(1):e109. https://doi.org/10.1002/cpsc.109 Zheng B, Ko KP, Fang X et al (2021) A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia. IScience 24(12):103440. https://doi.org/10.1016/j.isci.2021.103440 Fan N, Raatz L, Chon SH et al (2022) Subculture and Cryopreservation of esophageal adenocarcinoma organoids: pros and cons for single cell digestion. J Vis Exp. https://doi.org/10.3791/63281 Giobbe GG, Crowley C, Luni C et al (2019) Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture. Nat Commun 10(1):5658. https://doi.org/10.1038/s41467-019-13605-4 Naranjo JD, Saldin LT, Sobieski E et al (2020) Esophageal extracellular matrix hydrogel mitigates metaplastic change in a dog model of Barrett’s esophagus. Sci Adv 6(27):eaba4526. https://doi.org/10.1126/sciadv.aba4526 Curvello R, Kerr G, Micati DJ et al (2020) Engineered plant-based nanocellulose hydrogel for small intestinal organoid growth. Adv Sci (Weinh) 8(1):2002135. https://doi.org/10.1002/advs.202002135 Sorrentino G, Rezakhani S, Yildiz E et al (2020) Mechano-modulatory synthetic niches for liver organoid derivation. Nat Commun 11(1):3416. https://doi.org/10.1038/s41467-020-17161-0 Thrift AP (2016) The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol 41:88–95. https://doi.org/10.1016/j.canep.2016.01.013 Beydoun AS, Stabenau KA, Altman KW et al (2023) Cancer risk in Barrett’s esophagus: a clinical review. Int J Mol Sci 24(7):6018. https://doi.org/10.3390/ijms24076018 McDonald SAC, Lavery D, Wright NA et al (2015) Barrett oesophagus: lessons on its origins from the lesion itself. Nat Rev Gastroenterol Hepatol 12(1):50–60. https://doi.org/10.1038/nrgastro.2014.181 Kendall BJ, Whiteman DC (2006) Temporal changes in the endoscopic frequency of new cases of Barrett’s esophagus in an Australian health region. Am J Gastroenterol 101(6):1178–1182. https://doi.org/10.1111/j.1572-0241.2006.00548.x Spechler SJ, Souza RF (2014) Barrett’s esophagus. N Engl J Med 371(9):836–845. https://doi.org/10.1056/NEJMra1314704 Anaparthy R, Sharma P (2014) Progression of Barrett oesophagus: role of endoscopic and histological predictors. Nat Rev Gastroenterol Hepatol 11(9):525–534. https://doi.org/10.1038/nrgastro.2014.69 Liu X, Cheng Y, Abraham JM et al (2018) Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids. Cancer Lett 436:109–118. https://doi.org/10.1016/j.canlet.2018.08.017 Kunze B, Wein F, Fang HY et al (2020) Notch signaling mediates differentiation in Barrett’s esophagus and promotes progression to adenocarcinoma. Gastroenterology 159(2):575–590. https://doi.org/10.1053/j.gastro.2020.04.033 Anand A, Fang HY, Mohammad-Shahi D et al (2021) Elimination of NF-κB signaling in vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett’s esophagus. Carcinogenesis 42(3):405–413. https://doi.org/10.1093/carcin/bgaa109 Nakagawa H, Whelan K, Lynch JP (2015) Mechanisms of Barrett’s oesophagus: intestinal differentiation, stem cells, and tissue models. Best Pract Res Clin Gastroenterol 29(1):3–16. https://doi.org/10.1016/j.bpg.2014.11.001 Jiang M, Li H, Zhang Y et al (2017) Transitional basal cells at the squamous-columnar junction generate Barrett’s oesophagus. Nature 550(7677):529–533. https://doi.org/10.1038/nature24269 Nowicki-Osuch K, Zhuang L, Jammula S et al (2021) Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition. Science 373(6556):760–767. https://doi.org/10.1126/science.abd1449 Lee MH, Buterbaugh K, Richards-Kortum R et al (2012) Advanced endoscopic imaging for Barrett’s esophagus: current options and future directions. Curr Gastroenterol Rep 14(3):216–225. https://doi.org/10.1007/s11894-012-0259-3 Fang HY, Stangl S, Marcazzan S et al (2022) Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus. Eur J Nucl Med Mol Imaging 49(6):2049–2063. https://doi.org/10.1007/s00259-021-05582-y Sahm V, Maurer C, Baumeister T et al (2022) Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget 13:347–359. https://doi.org/10.18632/oncotarget.28198 Lin Y, Totsuka Y, He Y et al (2013) Epidemiology of esophageal cancer in Japan and China. J Epidemiol 23(4):233–242. https://doi.org/10.2188/jea.je20120162 Liu K, Zhao T, Wang J et al (2019) Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer. Cancer Lett 458:21–28. https://doi.org/10.1016/j.canlet.2019.05.018 Hayakawa Y, Nakagawa H, Rustgi AK et al (2021) Stem cells and origins of cancer in the upper gastrointestinal tract. Cell Stem Cell 28(8):1343–1361. https://doi.org/10.1016/j.stem.2021.05.012 Natsuizaka M, Whelan KA, Kagawa S et al (2017) Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 8(1):1758. https://doi.org/10.1038/s41467-017-01500-9 Kajiwara C, Fumoto K, Kimura H et al (2018) p63-dependent Dickkopf3 expression promotes esophageal cancer cell proliferation via CKAP4. Cancer Res 78(21):6107–6120. https://doi.org/10.1158/0008-5472.CAN-18-1749 Tang Q, Lento A, Suzuki K et al (2021) Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer. EMBO Rep 22(2):e48351. https://doi.org/10.15252/embr.201948351 Wu Z, Zhou J, Zhang X et al (2021) Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. Nat Genet 53(6):881–894. https://doi.org/10.1038/s41588-021-00859-2 Shimonosono M, Tanaka K, Flashner S et al (2021) Alcohol metabolism enriches squamous cell carcinoma cancer stem cells that survive oxidative stress via autophagy. Biomolecules 11(10):1479. https://doi.org/10.3390/biom11101479 Hruz P, Straumann A, Bussmann C et al (2011) Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 128:1349–1350. https://doi.org/10.1016/j.jaci.2011.09.013 Attwood SE, Smyrk TC, Demeester TR et al (1993) Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 38(1):109–116. https://doi.org/10.1007/BF01296781 Dellon ES, Liacouras CA (2014) Advances in clinical management of eosinophilic esophagitis. Gastroenterology 147(6):1238–1254. https://doi.org/10.1053/j.gastro.2014.07.055 Muir A, Falk GW (2021) Eosinophilic esophagitis: a review. JAMA 326(13):1310–1318. https://doi.org/10.1001/jama.2021.14920 Navarro P, Arias Á, Arias-González L, Laserna-Mendieta EJ, Ruiz-Ponce M, Lucendo AJ (2019) Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 49(9):1116–1125. https://doi.org/10.1111/apt.15231 Whelan KA, Merves JF, Giroux V et al (2017) Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis. Gut 66(7):1197–1207. https://doi.org/10.1136/gutjnl-2015-310341 Nakagawa H, Kasagi Y, Karakasheva TA et al (2020) Modeling epithelial homeostasis and reactive epithelial changes in human and murine three-dimensional esophageal organoids. Curr Protoc Stem Cell Biol 52(1):e106. https://doi.org/10.1002/cpsc.106 Kaymak T, Kaya B, Wuggenig P et al (2022) IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis. Gut. https://doi.org/10.1136/gutjnl-2022-327166 Akdis CA (2021) Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol 21(11):739–751. https://doi.org/10.1038/s41577-021-00538-7 Doyle AD, Masuda MY, Pyon GC et al (2023) Detergent exposure induces epithelial barrier dysfunction and eosinophilic inflammation in the esophagus. Allergy 78(1):192–201. https://doi.org/10.1111/all.15457 Hara T, Kasagi Y, Wang J et al (2022) CD73+ epithelial progenitor cells that contribute to homeostasis and renewal are depleted in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol 13(5):1449–1467. https://doi.org/10.1016/j.jcmgh.2022.01.018 van Lennep M, Singendonk MMJ, Dall’Oglio L et al (2019) Oesophageal atresia Nat Rev Dis Primers 5(1):26. https://doi.org/10.1038/s41572-019-0077-0 Spitz L, Kiely E, Pierro A (2004) Gastric transposition in children–a 21-year experience. J Pediatr Surg 39(3):276–281. https://doi.org/10.1016/j.jpedsurg.2003.11.032 Hamza AF, Abdelhay S, Sherif H et al (2003) Caustic esophageal strictures in children: 30 years’ experience. J Pediatr Surg 38(6):828–833. https://doi.org/10.1016/s0022-3468(03)00105-2 Bax NM, van der Zee DC (2007) Jejunal pedicle grafts for reconstruction of the esophagus in children. J Pediatr Surg 42(2):363–369. https://doi.org/10.1016/j.jpedsurg.2006.10.009 Spitz L (2007) Oesophageal atresia. Orphanet J Rare Dis 2:24. https://doi.org/10.1186/1750-1172-2-24 Low DE (2011) Update on staging and surgical treatment options for esophageal cancer. J Gastrointest Surg 15:719. https://doi.org/10.1007/s11605-011-1515-9 Spurrier RG, Speer AL, Hou X et al (2015) Murine and human tissue-engineered esophagus form from sufficient stem/progenitor cells and do not require microdesigned biomaterials. Tissue Eng Part A 21(5–6):906–915. https://doi.org/10.1089/ten.TEA.2014.0357 Trecartin A, Danopoulos S, Spurrier R et al (2016) Establishing proximal and distal regional identities in murine and human tissue-engineered lung and trachea. Tissue Eng Part C Methods 22(11):1049–1057. https://doi.org/10.1089/ten.TEC.2016.0261 Finkbeiner SR, Freeman JJ, Wieck MM et al (2015) Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids. Biol Open 4(11):1462–1472. https://doi.org/10.1242/bio.013235 Liu C, Qin T, Huang Y et al (2020) Drug screening model meets cancer organoid technology. Transl Oncol 13(11):100840. https://doi.org/10.1016/j.tranon.2020.100840 Baker EJ, Beck NA, Berg EL et al (2019) Advancing nonclinical innovation and safety in pharmaceutical testing. Drug Discov Today 24(2):624–628. https://doi.org/10.1016/j.drudis.2018.11.011 Caponigro G, Sellers WR (2011) Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov 10(3):179–187. https://doi.org/10.1038/nrd3385 Derouet MF, Allen J, Wilson GW et al (2020) Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor. Sci Rep 10(1):14514. https://doi.org/10.1038/s41598-020-71589-4 Shapiro J, van Lanschot JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098. https://doi.org/10.1016/S1470-2045(15)00040-6 Eyck BM, van Lanschot JJB, Hulshof MCCM et al (2021) 10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial). Eur J Surg Oncol 47:e31. https://doi.org/10.1200/JCO.20.03614 Dings MPG, van der Zalm AP, Bootsma S et al (2022) Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer. Cell Rep Med 3(11):100802. https://doi.org/10.1016/j.xcrm.2022.100802 Driehuis E, Kolders S, Spelier S et al (2019) Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov 9(7):852–871. https://doi.org/10.1158/2159-8290.CD-18-1522 Driehuis E, Kretzschmar K, Clevers H (2020) Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc 15(10):3380–3409. https://doi.org/10.1038/s41596-020-0379-4 Karakasheva TA, Gabre JT, Sachdeva UM et al (2021) Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer. Sci Rep 11(1):21304. https://doi.org/10.1038/s41598-021-00706-8 Zhou Z, Cong L, Cong X (2021) Patient-derived organoids in precision medicine: drug screening, organoid-on-a-chip and living organoid biobank. Front Oncol 11:762184. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank Kawasaki K, Toshimitsu K, Matano M et al (2020) An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell 183(5):1420–1435.e21. https://doi.org/10.1016/j.cell.2020.10.023 Nanki K, Toshimitsu K, Takano A et al (2018) Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis. Cell 174(4):856–869.e17. https://doi.org/10.1016/j.cell.2018.07.027 Pauli C, Hopkins BD, Prandi D et al (2017) Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov 7(5):462–477. https://doi.org/10.1158/2159-8290.CD-16-1154 Wörsdörfer P, I T, Asahina I, et al (2020) Do not keep it simple: recent advances in the generation of complex organoids. J Neural Transm (Vienna) 127(11):1569–1577. https://doi.org/10.1007/s00702-020-02198-8 Ma C, Peng Y, Li H et al (2021) Organ-on-a-chip: a new paradigm for drug development. Trends Pharmacol Sci 42(2):119–133. https://doi.org/10.1016/j.tips.2020.11.009 Trujillo-de Santiago G, Flores-Garza BG, Tavares-Negrete JA et al (2019) The tumor-on-chip: recent advances in the development of microfluidic systems to recapitulate the physiology of solid tumors. Materials (Basel) 12(18):2945. https://doi.org/10.3390/ma12182945 Cherne MD, Sidar B, Sebrell TA et al (2021) A synthetic hydrogel, VitroGel® ORGANOID-3, improves immune cell-epithelial interactions in a tissue chip co-culture model of human gastric organoids and dendritic cells. Front Pharmacol 12:707891. https://doi.org/10.3389/fphar.2021.707891 Lu S, Cuzzucoli F, Jiang J et al (2018) Development of a biomimetic liver tumor-on-a-chip model based on decellularized liver matrix for toxicity testing. Lab Chip 18(22):3379–3392. https://doi.org/10.1039/c8lc00852c Chen L, Wei X, Gu D et al (2023) Human liver cancer organoids: biological applications, current challenges, and prospects in hepatoma therapy. Cancer Lett 555:216048. https://doi.org/10.1016/j.canlet.2022.216048 Wang E, Xiang K, Zhang Y et al (2022) Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): new opportunities in establishing faithful pre-clinical cancer models. J Natl Cancer Cent 2(4):263–276. https://doi.org/10.1016/j.jncc.2022.10.001 Gao D, Vela I, Sboner A et al (2014) Organoid cultures derived from patients with advanced prostate cancer. Cell 159(1):176–187. https://doi.org/10.1016/j.cell.2014.08.016 Fujii M, Shimokawa M, Date S et al (2016) A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18(6):827–838. https://doi.org/10.1016/j.stem.2016.04.003 Lai Y, Wei X, Lin S et al (2017) Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol 10(1):106. https://doi.org/10.1186/s13045-017-0470-7 Bleijs M, van de Wetering M, Clevers H et al (2019). Xenograft and organoid model systems in cancer research. EMBO J 38(15):e101654. https://doi.org/10.15252/embj.2019101654 Lee SH, Hu W, Matulay JT et al (2018) Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173(2):515–528.e17. https://doi.org/10.1016/j.cell.2018.03.017